Skip to main content
. 2024 Jul 24;19(7):e0307984. doi: 10.1371/journal.pone.0307984

Table 2. Wald type II chi-square statistics of the linear mixed models for each HRQOL measure.

Variables χ 2 df P value
Physical Health (PCS)
Time 95.024 1 < .001*
Gender 15.049 1 < .001*
Time × gender 4.843 1 .028*
Comorbidity burden:
    Total comorbidity conditions 16.819 2 < .001*
    Charlson comorbidity categories 12.798 2 .002*
Comorbidity burden × gender:
    Total comorbidity conditions 9.448 2 .009*
    Charlson comorbidity categories 3.715 2 .156
Comorbidity burden × time:
    Total comorbidity conditions 0.348 2 .840
    Charlson comorbidity categories 0.990 2 .610
Mental health (MCS)
Time 44.794 1 < .001*
Gender 1.351 1 .245
Time × gender 0.206 1 .650
Comorbidity burden:
    Total comorbidity conditions 2.143 2 .343
    Charlson comorbidity categories 4.787 2 .091
Comorbidity burden × gender:
    Total comorbidity conditions 2.775 2 .250
    Charlson comorbidity categories 5.135 2 .077
Comorbidity burden × time:
    Total comorbidity conditions 4.823 2 .090
    Charlson comorbidity categories 2.344 2 .310
Disease-specific HRQoL (SAQ)
Time 248.309 1 < .001*
Gender 15.787 1 < .001*
Time × gender 1.564 1 .211
Comorbidity burden:
    Total comorbidity conditions 2.035 2 .362
    Charlson comorbidity categories 7.115 2 .029*
Comorbidity burden × gender:
    Total comorbidity conditions 13.761 2 .001*
    Charlson comorbidity categories 3.132 2 .209
Comorbidity burden × time
    Total comorbidity conditions 6.877 2 .032*
    Charlson comorbidity categories 0.906 2 .636

*P values < 0.05 were considered significant.